Nymox Pharmaceutical Corp. Faces $716,000 Loss in Q3
Nymox Pharmaceutical Corp. announces a Q3 loss of $716,000, highlighting challenges in the pharmaceutical sector. Explore the financial implications.
Nymox Pharmaceutical Corp. reported a loss of $716,000 in Q3.